Sydenham's chorea (SC) is a neurological disorder characterized by involuntary movements and is often associated with rheumatic fever, particularly in children. It is considered an immune-mediated ...
Please provide your email address to receive an email when new articles are posted on . According to a release from Neurocrine Biosciences Inc., the selective vesicular monoamine transporter 2 ...
NEW YORK (Reuters Health) - Group A streptococcal infection appears to be associated with changes in behavior and the development of a movement disorder in elementary school children, according to a ...
Movement disorders are neurological conditions characterised by impaired voluntary movements, the presence of involuntary movements, posture dysfunction, or normal-appearing movements at inappropriate ...
Neurocrine Biosciences Inc. NBIX said Friday that the U.S. Food and Drug Administration has approved Ingrezza for treatment of an involuntary movement disorder linked with Huntington’s disease, ...
Jagadeesha's brain, the first juvenile Huntington's Disease donation in India, offers hope for vital neurodegenerative research at NIMHANS.
Investor's Business Daily on MSN
Neurocrine Shares Rise, But Pull Back From Steep Gains, On Strong Ingrezza Quarter
In after-hours trades, Neurocrine stock rose a fraction to 148.30, peeling back from a stronger gain immediately after the ...
Our one-year pediatric movement disorders fellowship is designed to prepare child neurologists to become experts in the evaluation and treatment of conditions causing unwanted involuntary movements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback